Skip to main content
Michael Rome, MD, Cardiology, Tacoma, WA

Michael P Rome MD

Cardiology•Tacoma, WA

Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation

Physician

Join to View Full Profile

  • 1901 S Cedar StSuite 301 Cardiac Study Center, Inc., P.S.Tacoma, WA 98405

  • Phone+1 253-572-7320

  • Fax+1 253-627-3191

Are you Dr. Rome?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
Claim this profileNot you? Find your profile

Summary

  • Dr. Michael Rome, MD is a cardiologist in Tacoma, Washington. He is currently licensed to practice medicine in Washington, Oklahoma, and Ohio.

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterFellowship, Cardiovascular Disease, 1993 - 1995
  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Cardiovascular Disease, 1990 - 1993
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 1987 - 1990
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 1987

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1995 - 2026
  • OH State Medical License
    OH State Medical License 1988 - 2021
  • OK State Medical License
    OK State Medical License 1993 - 2018
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Clinical Cardiac Electrophysiology
    American Board of Internal Medicine Clinical Cardiac Electrophysiology

Publications & Presentations

PubMed

Press Mentions

  • Four IPOs and a SPAC Pitch a New Slate of Microbiome, Cancer and Inflammatory Drugs to Wall Street
    Four IPOs and a SPAC Pitch a New Slate of Microbiome, Cancer and Inflammatory Drugs to Wall StreetMarch 1st, 2021
  • After Kymera's Raise, Nurix Nabs $120M as It Too Hones in on Clinical Work
    After Kymera's Raise, Nurix Nabs $120M as It Too Hones in on Clinical WorkMarch 13th, 2020
  • Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline
    Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug PipelineMarch 12th, 2020

Dr. Michael Rome, Dr. Michael Rome, MD, Dr. M Rome, Dr. Michael P Rome